Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
Holders of 5% or more of BIOC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biocept Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Biocept Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Biocept Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | Lind Global Fund II LP | 13GOld format | – | New | – | SEC |
| Jan 5, 2021 | Sabby Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Biocept Inc shares.
No Form 144 notices for Biocept Inc are on file.